-
Lundbeck announces last patient randomized in DEEp SEA, a Phase III trial of bexicaserin in Dravet syndrome
- September 15, 2026
- Posted by:
- Category: News
No Comments
DEEp SEA is a global Phase III trial evaluating efficacy, safety and tolerability of the investigational molecule bexicaserin in children and adults with Dravet syndrome1Completion of randomization marks another important milestone for the global Phase III DEEp program,…
-
Scania G-series and R-series achieve five-star Euro NCAP results
- September 15, 2026
- Posted by: Megan Foster
- Category: Business plans
SÖDERTÄLJE, Sweden, Sept. 15, 2026 /PRNewswire/ — Scania’s G-series and R-series have been awarded five stars in Euro NCAP’s haulage assessment, with a 96 percent score for crash avoidance. The results reflect Scania’s continued focus on visibility, driver…
-
Corteva Categorically Rejects Unfounded, Unprecedented Allegations by State Attorneys General
- September 14, 2026
- Posted by: Jessica Turner
- Category: Finance & accounting
Future crop protection company will be a strongly capitalized market leader with compelling value proposition for farmers, shareholdersINDIANAPOLIS, Sept. 14, 2026 /PRNewswire/ — Corteva, Inc. (NYSE: CTVA) categorically rejects the attempt by a number of State Attorneys General…